The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Progression of Coronary Artery Disease Predicts Clinical Coronary Events: Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study
Abstract
Background Progression of coronary artery disease is assumed to be a surrogate end point for clinical coronary events. Because no single method or measure for a coronary angiographic end point is uniformly accepted as optimal, the utility and validity of surrogate end points for predicting clinical coronary events remain unsettled. Methods and Results The Cholesterol Lowering Atherosclerosis Study randomized 162 nonsmoking, 40- to 59-year-old men with previous coronary artery bypass graft surgery to colestipol/niacin plus diet or placebo plus diet. Atherosclerosis change on 2-year coronary angiograms was evaluated by a consensus panel and by quantitative coronary angiography (average per-subject change in percent diameter stenosis [%S] and minimum lumen diameter [MLD]). With all three end points, the benefit of colestipol/niacin treatment on coronary artery atherosclerosis has been reported. Annual follow-up for an average of 7 years (range, 6.3 months to 10 years) has been carried out on all subjects who completed the 2-year angiogram. Clinical coronary events (need for revascularization, nonfatal acute myocardial infarction, and coronary death) have been documented. Risk of clinical coronary events was positively related to coronary lesion progression for all three surrogate end points ( P <.05). New lesion formation in bypass grafts ( P =.02) and progression of mild/moderate lesions (<50%S) were predictive of clinical coronary events ( P <.01). Change in MLD contributed significantly to the prediction of clinical coronary events beyond a model with %S alone ( P <.05). Conclusions In this population of nonsmoking men with previous bypass surgery, both the consensus panel– and quantitative coronary angiography–based end points of coronary artery disease progression predict clinical coronary events. Subjects who demonstrate greater coronary artery lesion progression have an increased risk of future clinical coronary events. Design of shorter, smaller trials of antiatherosclerotic agents is justified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can lifestyle changes reverse coronary heart disease?
Ornish, D., Brown, S. E., Billings, J. H., Scherwitz, L. W., Armstrong, W. T., Ports, T. A., McLanahan, S. M., Kirkeeide, R. L., Gould, K. L., & Brand, R. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91656-u · Cited by 2,338
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
Self-citationPrognostic significance of progression of coronary artery disease
Moise, A., Bourassa, M. G., Théroux, P., Taeymans, Y., Pasternac, A., Campeau, L., Bois, M. A., Dyrda, I., & David, P. R. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90722-2 · Cited by 56
Cited by
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Brown, B. G., Ganz, P., Vogel, R. A., Crowe, T., Howard, G., Cooper, C. J., Brodie, B., et al. (2004) · JAMA · doi:10.1001/jama.291.9.1071 · Cited by 2,361
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217
“The association of advanced coronary atherosclerotic lesions with risk factors and risk for coronary events has been determined by serial coronary angiography (4-6, 23, 24).”
BackgroundResultInfluentialSelf-citationScanlon, P. J., Faxon, D. P., Audet, A.-M., Carabello, B., Dehmer, G. J., Eagle, K. A., Legako, R. D., Leon, D. F., Murray, J. A., Nissen, S. E., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00126-6 · Cited by 1,123
Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995
Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.8.2013 · Cited by 915
Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V. G., Lie, K. I., & Kastelein, J. J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380203 · Cited by 625
Waters, D. D., Alderman, E. L., Hsia, J., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P., Tardif, J. C., Higginson, L., et al. (2002) · JAMA · doi:10.1001/jama.288.19.2432 · Cited by 577
Drobni, Z. D., Alvi, R. M., Taron, J., Zafar, A., Murphy, S. P., Rambarat, P. K., Mosarla, R. C., Lee, C., Zlotoff, D. A., Raghu, V. K., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.049981 · Cited by 560
Taylor, A. J., Kent, S. M., Flaherty, P. J., Coyle, L. C., Markwood, T. T., & Vernalis, M. N. (2002) · Circulation · doi:10.1161/01.cir.0000034508.55617.65 · Cited by 558
Willeit, P., Tschiderer, L., Allara, E., Reuber, K., Seekircher, L., Gao, L., Liao, X., Lonn, E., Gerstein, H. C., Yusuf, S., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046361 · Cited by 452
Esposito, K., Giugliano, D., Nappo, F., & Marfella, R. (2004) · Circulation · doi:10.1161/01.cir.0000134501.57864.66 · Cited by 440
Yamagishi, M., Terashima, M., Awano, K., Kijima, M., Nakatani, S., Daikoku, S., Ito, K., Yasumura, Y., & Miyatake, K. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00533-1 · Cited by 435
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption
Mann, J., & Davies, M. J. (1999) · Heart · doi:10.1136/hrt.82.3.265 · Cited by 430
Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tuzcu, E. M., Brewer, H. B., Sipahi, I., Nicholls, S. J., Ganz, P., Schoenhagen, P., Waters, D. D., Pepine, C. J., Crowe, T. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054699 · Cited by 398
Frick, M. H., Syvänne, M., Nieminen, M. S., Kauma, H., Majahalme, S., Virtanen, V., Kesäniemi, Y. A., Pasternack, A., & Taskinen, M.-R. (1997) · Circulation · doi:10.1161/01.cir.96.7.2137 · Cited by 388
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women
Hodis, H. N., Mack, W. J., Azen, S. P., Lobo, R. A., Shoupe, D., Mahrer, P. R., Faxon, D. P., Cashin-Hemphill, L., Sanmarco, M. E., French, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030830 · Cited by 386
Self-citationHerd, J. A., Ballantyne, C. M., Farmer, J. A., Ferguson, J. J., Jones, P. H., West, M. S., Gould, K. L., & Gotto, A. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00346-9 · Cited by 315
Belcaro, G. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00665-1 · Cited by 289
Knatterud, G. L., Rosenberg, Y., Campeau, L., Geller, N. L., Hunninghake, D. B., Forman, S. A., Forrester, J. S., Gobel, F. L., Herd, J. A., Hickey, A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.157 · Cited by 274
Coronary Artery Calcium Progression: An Important Clinical Measurement?
McEvoy, J. W., Blaha, M. J., DeFilippis, A. P., Budoff, M. J., Nasir, K., Blumenthal, R. S., & Jones, S. R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.038 · Cited by 255
Progression of Peripheral Arterial Disease Predicts Cardiovascular Disease Morbidity and Mortality
Criqui, M. H., Ninomiya, J. K., Wingard, D. L., Ji, M., & Fronek, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.060 · Cited by 253
Nicholls, S. J., Tuzcu, E. M., Sipahi, I., Schoenhagen, P., Crowe, T., Kapadia, S., & Nissen, S. E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.040 · Cited by 147
Short-term progression of multiterritorial subclinical atherosclerosis
López-Melgar, B., Fernández-Friera, L., Oliva, B., García-Ruiz, J. M., Sánchez-Cabo, F., Bueno, H., Mendiguren, J. M., Lara-Pezzi, E., Andrés, V., Ibáñez, B., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.026 · Cited by 103
Hsia, J., Bittner, V., Tripputi, M., & Howard, B. V. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00227-8 · Cited by 43
Dietary macronutrients, genetic variation, and progression of coronary atherosclerosis among women
Kalantarian, S., Rimm, E. B., Herrington, D. M., & Mozaffarian, D. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.01.001 · Cited by 8
Metadata
- Authors
- Azen, S. P., Mack, W. J., Cashin-Hemphill, L., LaBree, L., Shircore, A. M., Selzer, R. H., Blankenhorn, D. H., & Hodis, H. N.
- Venue
- Circulation
- Published
- 1996-01
- Volume
- 93
- Issue
- 1
- Pages
- 34-41
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2003188915
- Cited by
- 215
- References
- 6
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.